SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Atlas Venture Fund XI, L.P., a major venture capital insider, filed a…

Dyne Therapeutics, Inc. · 144 filed Aug 13, 2026 at 17:36 ET

At the news

BEARISHIMPACT 6/10

144 filed Aug 13, 2026 at 17:36 ET

Atlas Venture Fund XI, L.P., a major venture capital insider, filed a Form 144 on August 13, 2026, indicating intent to sell 268,354 shares of Dyne Therapeutics (DYN) with an approximate market value of $7.0 million. Separately, Director John Cox also filed a Form 144 on the same day, signaling a proposed sale. The Atlas Venture sale represents a significant insider liquidation by a founding investor, which is a bearish signal for the stock, especially given the company's pre-revenue status and reliance on pipeline catalysts. The batch of filings on the same day amplifies the negative sentiment, suggesting coordinated insider selling.

  • Atlas Venture Fund XI, L.P. filed Form 144 to sell 268,354 shares of DYN, valued at approximately $7.0 million based on the filing date.
  • Director John Cox also filed a Form 144 on the same day, indicating a proposed sale of an undisclosed number of shares.
  • The Atlas Venture sale represents a significant portion of their holdings, as they are a founding venture capital investor.
  • The filing date is August 13, 2026, with the proposed sale to occur on or after that date.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access